Figure 3From: Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+ Chemosensitivity of Adeno-2B6/p35-infected tumor cells to cisplatin and doxorubicin. Growth inhibition assays showing that Adeno-2B6- and Adeno-2B6/p35-infected U251 cells are equally chemosensitive and can be killed completely by a 4-day continuous exposure to 40 μM cisplatin (A) or 0.16 μM doxorubicin (B).Back to article page